Massimo Breccia

Pubblicazioni

Titolo Pubblicato in Anno
LONG TERM OUTCOME OF INTERMITTENT IMATINIB TREATMENT POLICY FOR MANAGING CHRONIC MYELOID LEUKEMIA IN THE ELDERLY HAEMATOLOGICA 2015
JAK2V617F-Positive Patients with Essential Thrombocythemia or Early Primary Myelofibrosis: The Impact of Histological Diagnosis on Outcome BLOOD 2015
SMOOTHENED (SMO) INHIBITOR LDE225 COMBINED WITH NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT (R/I) TO AT LEAST 1 PRIOR TYROSINE KINASE INHIBITOR: A PHASE 1B STUDY HAEMATOLOGICA 2015
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations LEUKEMIA RESEARCH 2015
RECEIVER OPERATING CHARACTERISTIC ANALYSIS AS A TOOL TO IDENTIFY THRESHOLD VALUES OF CONTINOUS RISK FACTORS FOR THROMBOSIS AND SURVIVAL IN ESSENTIAL THROMBOCITEMIA: A RETROSPECTIVE ANALYSIS ON 1250 PATIENTS HAEMATOLOGICA 2015
Event-Free Survival According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: The Younger, the Later, the Worse? BLOOD 2015
SEX CORRELATED WITH DIFFERENCES IN LONG-TERM OUTCOME IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB HAEMATOLOGICA 2015
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS (TKIS) HAEMATOLOGICA 2015
EFFICACY OF RUXOLITINIB IN MYELOFIBROSIS PATIENTS WITHOUT SPLENOMEGALY HAEMATOLOGICA 2015
"REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA HAEMATOLOGICA 2015
LONG-TERM VALUE OF FLUCTUATION OF MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB HAEMATOLOGICA 2015
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes BRITISH JOURNAL OF HAEMATOLOGY 2015
Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis BLOOD 2015
PML/RAR KINETICS AND IMPACT OF FLT3-ITD MUTATIONS IN NEWLY DIAGNOSED LOW-INTERMEDIATE RISK ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ATRA AND ATO OR ATRA AND CHEMOTHERAPY HAEMATOLOGICA 2015
A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS HAEMATOLOGICA 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma